Fluoxetine
Learn what this care may do. See what research says. Then check where to get care. A place may not be taking new patients.
identity
Fluoxetine (sold under brand names such as Prozac; this page cites a Lupin Fluoxetine Hydrochloride capsule label) is a prescription medicine. Its U.S. product labeling lists obsessive-compulsive disorder (OCD) among the conditions it is indicated to treat.
DailyMed fluoxetine hydrochloride label · checked Sep 19, 2026
why-linked
EveryOption includes fluoxetine for OCD because the DailyMed Fluoxetine Hydrochloride label’s Indications and Usage section names Obsessive Compulsive Disorder as a labeled indication for adults and for pediatric patients 7 to 17 years of age. That label statement was checked against this source. A clinical evidence assessment of how well fluoxetine works for OCD has not yet been published here.
DailyMed fluoxetine hydrochloride label · checked Sep 19, 2026
indication-quote
Obsessive Compulsive Disorder (OCD)
DailyMed fluoxetine hydrochloride label · checked Sep 19, 2026
scope
This page explains why the option appears and what the cited label supports. It does not set dosing, compare treatments, or report availability. Access information is not shown here.
DailyMed fluoxetine hydrochloride label · checked Sep 19, 2026
provenance
Cited source: DailyMed (U.S. National Library of Medicine) structured product label for Fluoxetine Hydrochloride capsules (Lupin Pharmaceuticals, Inc.), SET ID f274f102-67ec-46e7-b248-533be2e3003b, version 5, Indications and Usage. Hosting on DailyMed is not a license to republish the full label.
DailyMed fluoxetine hydrochloride label · checked Sep 19, 2026
Published Need relationships
Select an exact Need to inspect its scoped research. Published conclusions appear first; uses without one follow under Not reviewed. This order is not a personal recommendation.
Research we have checked
Bulimia Nervosa
DailyMed fluoxetine hydrochloride label · checked Sep 19, 2026
Relationship: label-reported clinical studies for the Need
Scope: country:US
Pointer: /sections/4
Supporting passage: The effectiveness of fluoxetine for the treatment of bulimia was demonstrated in two 8-week and one 16-week, multicenter, parallel-group studies of adult outpatients meeting DSM-III-R criteria for bulimia.
Open sourceRead exact answerResearch suggests benefit in this exact scope
Published Sep 20, 2026 · revision 1
Major Depressive Disorder
DailyMed fluoxetine hydrochloride label · checked Sep 19, 2026
Relationship: label-reported clinical studies for the Need
Scope: country:US
Pointer: /sections/4
Supporting passage: The efficacy of fluoxetine was studied in 5- and 6-week placebo-controlled trials with depressed adult and geriatric outpatients (≥ 18 years of age) whose diagnoses corresponded most closely to the DSM-III (currently DSM-IV) category of MDD.
Open sourceRead exact answerResearch suggests benefit in this exact scope
Published Sep 20, 2026 · revision 1
Panic Disorder
DailyMed fluoxetine hydrochloride label · checked Sep 19, 2026
Relationship: label-reported clinical studies for the Need
Scope: country:US
Pointer: /sections/4
Supporting passage: The effectiveness of fluoxetine in the treatment of Panic Disorder was demonstrated in 2 double-blind, randomized, placebo-controlled, multicenter studies of adult outpatients who had a primary diagnosis of Panic Disorder (DSM-IV), with or without agoraphobia.
Open sourceRead exact answerResearch suggests benefit in this exact scope
Published Sep 20, 2026 · revision 1
Not reviewed
Obsessive-Compulsive Disorder
DailyMed fluoxetine hydrochloride label · checked Sep 19, 2026
Read exact answerNot reviewed
No current published assessment exists for this exact Treatment and Need. This does not establish benefit or no benefit.
Next: check access
Research and local availability are different facts. Add a place to see known, source-backed access options for Fluoxetine.
Find accessSee something wrong? Tell us. Your note is private. We check sources before we change this page.